SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

UPDATE: Raymond James On Medtronic Notes 'There seemed to be a modest slippage in the pipeline, but we believe this dynamic actually creates a better set-up for growth entering F21. Revenue growth should accelerate in F4Q and in F21'

Benzinga · -